Hippocampus mitochondrial MnSOD activation by a SIRT3 activator, honokiol, correlates with its deacetylation and upregulation of FoxO3a and PGC1α in a rat model of ammonia neurotoxicity
- 15 March 2023
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 124 (4), 606-618
- https://doi.org/10.1002/jcb.30393
Abstract
We have recently reported that honokiol (HKL), by activating mitochondrial SIRT3, normalizes reactive oxygen species level and mitochondrial integrity in hippocampus of the moderate grade hepatic encephalopathy (MoHE) rat model of ammonia neurotoxicity. To delineate the mechanism by which HKL does so, the present study describes activity versus level of the deacetylated mitochondrial Mn-superoxide dismutase (MnSOD) and expression of MnSOD versus levels of its main transcription regulators, FoxO3a and PGC1 alpha, in the hippocampus of the MoHE rats. MoHE in rat was developed by administration of 100 mg/kg bw thioacetamide i.p. for 10 days. The study parameters were compared between the control, the MoHE rats and the MoHE rats treated with HKL (10 mg/Kg b.w.) for 7 days. As compared to control, the hippocampus mitochondria from MoHE rats showed a significantly declined activity of MnSOD vs enhanced lipid peroxidation coinciding with the increased level of its acetylated form. The HKL treatment could, however, normalize all these parameters in those MoHE rats. Also, a significantly reduced expression of MnSOD in the hippocampus of the MoHE rats coincided with a similar decline in transcript level of Foxo3a and Pgc1 alpha. This was consistent with the reduced level of immuno-stained Foxo3a and Pgc1 alpha proteins in hippocampus DG, CA1 and CA3 regions of those MoHE rats. However, all these factors were observed to be restored back to their normal levels due to the treatment with HKL. As HKL is a specific activator of mitochondrial SIRT3, these findings suggest involvement of Sirt3 activation led deacetylation of MnSOD and upregulation of its transcription activators, FoxO3a and PGC1 alpha, in restoring mitochondrial MnSOD level in the hippocampus of the MoHE rat model of ammonia neurotoxicity.Keywords
Funding Information
- Science and Engineering Research Board (EMR/2016/006501)
This publication has 43 references indexed in Scilit:
- Neuro-Modulating Effects of Honokiol: A ReviewFrontiers in Neurology, 2013
- Manganese superoxide dismutase, MnSOD and its mimicsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- SIRT3 Is a Mitochondrial Tumor Suppressor: A Scientific Tale That Connects Aberrant Cellular ROS, the Warburg Effect, and CarcinogenesisCancer Research, 2012
- Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathyMetabolic Brain Disease, 2011
- Honokiol Crosses BBB and BCSFB, and Inhibits Brain Tumor Growth in Rat 9L Intracerebral Gliosarcoma Model and Human U251 Xenograft Glioma ModelPLOS ONE, 2011
- Mutual Dependence of Foxo3a and PGC-1α in the Induction of Oxidative Stress GenesOnline Journal of Public Health Informatics, 2009
- PGC-1α/β induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disordersHuman Molecular Genetics, 2009
- PGC-1α Expression Decreases in the Alzheimer Disease Brain as a Function of DementiaArchives of Neurology, 2009
- Glutamine‐induced free radical production in cultured astrocytesGlia, 2004
- Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stressNature, 2002